NFKB1 and chronic obstructive pulmonary disease: In COPD, the activation of NF-κB is mediated through the phosphorylation of IκBα and regulates the production of inflammatory mediators, such as cytokines and chemokines, resulting in the development and aggravation of inflammatory responses in damaged lesions [6].